Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,811
+$1,736 QoQ
Shares Held
16,570
+426.9% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 48 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. VTGN ranks #335 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in VTGN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,811 16,570
2025-12-31 $2,075 3,145
2025-09-30 $123,031 34,657
2025-06-30 $6,756 3,378
2025-03-31 $1,692 677
2024-12-31 $62,365 21,141
2024-09-30 $5,447 1,810
2024-06-30 $827 238
2024-03-31 $53,480 10,129
2023-12-31 $99,710 19,399
2023-09-30 $3,316 633
2023-06-30 $1,181 632
2023-03-31 $9,869 82,259
2022-12-31 $12,474 124,747
2022-09-30 $66,353 442,364
2022-06-30 $6,912 7,856
2022-03-31 $192,292 155,077
2021-12-31 $1,043,900 535,334
2021-09-30 $2,290 836
2021-06-30 $7,294 2,316